ReviewJournal of diabetes research2021

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes.

Habib Yaribeygi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.